Abstract
Traditional approaches to understanding the origins of chronic pancreatitis (CP) and find treatments led to abysmal failure. Thus, no drugs now exists to meet this need. Outdated concepts of the etiopathogenesis of CP have been replaced with new insights and disease models that provide the framework for early detection of the pathogenic pancreatitis process. Application of these principals require a new paradigm in disease definition and management, i.e. personalized / precision medicine. The key is acute pancreatitis (AP) starting with the first (sentinel) acute pancreatitis (AP) event (SAPE). This event sensitizes the pancreas to recurrent acute pancreatitis (RAP) as ongoing stressors drive various inflammatory responses to cause CP. The problem is the complex etiologies of AP and the additional genetic and environmental factors that promote progression to RAP and CP. This paper provides a background on the key conceptual changes that facilitate new approaches and the rationale for using mechanism-specific therapies to prevent RAP and CP.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Subject
Pediatrics, Perinatology and Child Health
Reference59 articles.
1. Ueber selbstverdauung des menschlichen pankreas [Autodigestion of the human pancreas];Chiari;Zeitschrift fur Heilkunde.,1896
2. Chronic pancreatitis;Steer;N Engl J Med.,1995
3. What is personalized medicine and what should it replace?;Whitcomb;Nat Rev Gastroenterol Hepatol,2012
4. Primer on precision medicine for complex chronic disorders;Whitcomb;Clin Transl Gastroenterol.,2019
5. Pathogenesis of chronic pancreatitis;Sarles;Gut.,1990
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献